These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 38332519)

  • 1. Temporal dynamics and drivers of durable HIV viral load suppression and persistent high- and low-level viraemia during Universal Test and Treat scale-up in Uganda: a population-based study.
    Rosen JG; Ssekubugu R; Chang LW; Ssempijja V; Galiwango RM; Ssekasanvu J; Ndyanabo A; Kisakye A; Nakigozi G; Rucinski KB; Patel EU; Kennedy CE; Nalugoda F; Kigozi G; Ratmann O; Nelson LJ; Mills LA; Kabatesi D; Tobian AAR; Quinn TC; Kagaayi J; Reynolds SJ; Grabowski MK
    J Int AIDS Soc; 2024 Feb; 27(2):e26200. PubMed ID: 38332519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal dynamics and drivers of durable HIV viral load suppression and persistent high- and low-level viremia during Universal Test and Treat scale-up in Uganda: a population-based study.
    Rosen JG; Ssekubugu R; Chang LW; Ssempijja V; Galiwango RM; Ssekasanvu J; Ndyanabo A; Kisakye A; Nakigozi G; Rucinski KB; Patel EU; Kennedy CE; Nalugoda F; Kigozi G; Ratmann O; Nelson LJ; Mills LA; Kabatesi D; Tobian AAR; Quinn TC; Kagaayi J; Reynolds SJ; Grabowski MK
    medRxiv; 2023 Jun; ():. PubMed ID: 37398460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study.
    Grabowski MK; Patel EU; Nakigozi G; Ssempijja V; Ssekubugu R; Ssekasanvu J; Ndyanabo A; Kigozi G; Nalugoda F; Gray RH; Kalibbala S; Serwadda DM; Laeyendecker O; Wawer MJ; Chang LW; Quinn TC; Kagaayi J; Tobian AAR; Reynolds SJ
    J Infect Dis; 2021 Apr; 223(7):1150-1160. PubMed ID: 33471100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Health Facility Switching and Associations With HIV Viral Rebound Among Persons on Antiretroviral Therapy in Uganda: A Population-based Study.
    Rosen JG; Ndyanabo A; Nakawooya H; Galiwango RM; Ssekubugu R; Ssekasanvu J; Kim S; Rucinski KB; Nakigozi G; Nalugoda F; Kigozi G; Quinn TC; Chang LW; Kennedy CE; Reynolds SJ; Kagaayi J; Grabowski MK
    Clin Infect Dis; 2024 Jun; 78(6):1591-1600. PubMed ID: 38114162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.
    Jain V; Petersen ML; Liegler T; Byonanebye DM; Kwarisiima D; Chamie G; Sang N; Black D; Clark TD; Ladai A; Plenty A; Kabami J; Ssemmondo E; Bukusi EA; Cohen CR; Charlebois ED; Kamya MR; Havlir DV;
    Lancet HIV; 2017 Mar; 4(3):e122-e133. PubMed ID: 27989576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
    Kiweewa F; Esber A; Musingye E; Reed D; Crowell TA; Cham F; Semwogerere M; Namagembe R; Nambuya A; Kafeero C; Tindikahwa A; Eller LA; Millard M; Gelderblom HC; Keshinro B; Adamu Y; Maswai J; Owuoth J; Sing'oei VC; Maganga L; Bahemana E; Khamadi S; Robb ML; Ake JA; Polyak CS; Kibuuka H
    PLoS One; 2019; 14(2):e0211344. PubMed ID: 30721233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    Szubert AJ; Prendergast AJ; Spyer MJ; Musiime V; Musoke P; Bwakura-Dangarembizi M; Nahirya-Ntege P; Thomason MJ; Ndashimye E; Nkanya I; Senfuma O; Mudenge B; Klein N; Gibb DM; Walker AS;
    PLoS Med; 2017 Nov; 14(11):e1002432. PubMed ID: 29136032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population prevalence of antiretroviral therapy sharing and its association with HIV viremia in rural Uganda: a cross-sectional population-based study.
    Kennedy CE; Feng X; Ssekubugu R; Rosen JG; Ssekasanvu J; Kigozi G; Serwadda D; Yeh PT; Kagaayi J; Quinn TC; Tobian AAR; Wawer MJ; Reynolds SJ; Chang LW; Grabowski MK; Nalugoda F
    J Int AIDS Soc; 2023 Sep; 26(9):e26135. PubMed ID: 37705364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super learner analysis of real-time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non-differentiated care approaches for persons living with HIV in rural Uganda.
    Benitez AE; Musinguzi N; Bangsberg DR; Bwana MB; Muzoora C; Hunt PW; Martin JN; Haberer JE; Petersen ML
    J Int AIDS Soc; 2020 Mar; 23(3):e25467. PubMed ID: 32202067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
    Teira R; Vidal F; Muñoz-Sánchez P; Geijo P; Viciana P; Ribera E; Domingo P; Castaño M; Martínez E; Roca B; Puig T; Estrada V; Deig E; Galindo MJ; de la Fuente B; Lozano F; Montero M; Muñoz-Sanz A; Sanchez T; Terrón A; Romero-Palacios A; Lacalle JR; Garrido M; Suárez-Lozano I;
    HIV Med; 2017 Mar; 18(3):196-203. PubMed ID: 27476742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study.
    Chun HM; Abutu A; Milligan K; Ehoche A; Shiraishi RW; Odafe S; Dalhatu I; Onotu D; Okoye M; Oladipo A; Gwamna J; Ikpeazu A; Akpan NM; Ibrahim J; Aliyu G; Akanmu S; Boyd MA; Swaminathan M; Ellerbrock T; Stafford KA; Dirlikov E;
    Lancet Glob Health; 2022 Dec; 10(12):e1815-e1824. PubMed ID: 36400087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure.
    McCluskey SM; Boum Y; Musinguzi N; Haberer JE; Martin JN; Hunt PW; Marconi VC; Bangsberg DR; Siedner MJ
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):183-187. PubMed ID: 28628529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying longitudinal patterns of HIV treatment (dis)engagement and re-engagement from oral histories of virologically unsuppressed persons in Uganda: A thematic trajectory analysis.
    Rosen JG; Nakyanjo N; Ddaaki WG; Zhao T; Van Vo A; Nakubulwa R; Ssekyewa C; Isabirye D; Katono RL; Nabakka P; Ssemwanga RJ; Kigozi G; Odiya S; Nakigozi G; Nalugoda F; Kigozi G; Kagaayi J; Grabowski MK; Kennedy CE
    Soc Sci Med; 2023 Dec; 339():116386. PubMed ID: 37984182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
    Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
    J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
    Nanyeenya N; Nakanjako D; Makumbi F; Nakigozi G; Nalugoda F; Kigozi G; Nasuuna E; Kibira SPS; Nabadda S; Kiyaga C; Huzaifah M; Kiwanuka N
    HIV Med; 2024 Feb; 25(2):245-253. PubMed ID: 37853605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis.
    Atuhaire P; Hanley S; Yende-Zuma N; Aizire J; Stranix-Chibanda L; Makanani B; Milala B; Cassim H; Taha T; Fowler MG
    PLoS One; 2019; 14(10):e0219415. PubMed ID: 31647806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.
    Prendergast AJ; Szubert AJ; Pimundu G; Berejena C; Pala P; Shonhai A; Hunter P; Arrigoni FIF; Musiime V; Bwakura-Dangarembizi M; Musoke P; Poulsom H; Kihembo M; Munderi P; Gibb DM; Spyer MJ; Walker AS; Klein N;
    AIDS; 2021 Aug; 35(10):1537-1548. PubMed ID: 34270487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda.
    Nanyeenya N; Chang LW; Kiwanuka N; Nasuuna E; Nakanjako D; Nakigozi G; Kibira SPS; Nabadda S; Kiyaga C; Makumbi F
    PLoS One; 2023; 18(1):e0279479. PubMed ID: 36638086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV viral load non-suppression and associated factors among pregnant and postpartum women in rural northeastern South Africa: a cross-sectional survey.
    Ngandu NK; Lombard CJ; Mbira TE; Puren A; Waitt C; Prendergast AJ; Tylleskär T; Van de Perre P; Goga AE
    BMJ Open; 2022 Mar; 12(3):e058347. PubMed ID: 35273061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression.
    Elén S; Björkman P; Zazzi M; Böhm M; Bernal E; Sönnerborg A; Elvstam O;
    HIV Med; 2024 Jan; 25(1):107-116. PubMed ID: 37721192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.